Philosophy and strategy: a fully integrated specialty pharma group with sustainable growth
_Vifor Pharma is an internationally active pharma company, which researches, develops, produces and markets its own pharmaceutical products. The company has three main areas of focus: iron deficiency, which is linked to a host of illnesses, the pharmaceutical company OM Pharma, with a focus on infectious diseases/OTX products, and activities of Consumer Healthcare, with a focus on OTC products).
Activity
_Vifor Pharma focuses its activities on iron deficiency, a widespread ailment around the world. It develops and manufactures pharmaceutical products. The iron replacement products Ferinject®, Venofer® and Maltofer® are international leaders. To gain rapid and direct access to the various international markets, Vifor Pharma works with its own sales affiliates as well as with partners.
_The OM Pharma products, such as Broncho-Vaxom® and Uro-Vaxom®, supplement the portfolio of Vifor Pharma and offer significant potential for expansion.
_Consumer Healthcare manufactures and markets OTC products developed within the Group, as well as products manufactured or sold under licence. Vifor Pharma plays a leading role in the area of non-prescription medicines, both in Switzerland and in selected countries of export. Major products include Equazen eyeq™, Perskindol® and Algifor®.
Links